1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow repotrectinib: new trials by email Literature Review of repotrectinib trials Research Report on repotrectinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients Repotrectinib, Osimertinib - Nsclc | Phase 1 | Unknown | Instituto Oncológico Dr Rosell | 32 | 2022-02-11 | 2024-04-03 |
Carcinoma, Non-Small-Cell Lung (1)
Instituto Oncológico Dr Rosell (1)
Spain (1)